Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results
Director comp.
CC transcript

PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPDI) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/08/2021 3/A PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 3/A on Science 37 Holdings, Inc.
10/18/2021 3 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 3 on Science 37 Holdings, Inc.
08/01/2018 4 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 4 on Liquidia Technologies Inc
Txns: Converted 442,819 shares @ $0
Converted 3,420,516 preferred shares @ $0
07/25/2018 3 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 3 on Liquidia Technologies Inc
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 4 Hill Raymond H (CEO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 30,000 restricted stock units @ $0
Disposed/sold 150,000 options to buy @ $28.54, valued at $4.3M
12/06/2011 4 SNYDERMAN RALPH (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 1,139 shares @ $33.25, valued at $37.9k
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
12/06/2011 4 Sharbaugh William J (COO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Unknown transaction of 324 shares @ $24.98, valued at $8.1k
Disposed/sold 13,906 shares @ $33.25, valued at $462.4k
Disposed/sold 45,000 options to buy @ $27.27, valued at $1.2M
Disposed/sold 30,000 options to buy @ $26.64, valued at $799.2k
Disposed/sold 62,104 options to buy @ $20.45, valued at $1.3M
Disposed/sold 62,104 options to buy @ $25.74, valued at $1.6M
Disposed/sold 27,947 options to buy @ $19.94, valued at $557.3k
Disposed/sold 27,947 options to buy @ $37.69, valued at $1.1M
Disposed/sold 62,104 options to buy @ $43.26, valued at $2.7M
Disposed/sold 77,630 options to buy @ $35.26, valued at $2.7M
Disposed/sold 15,000 restricted stock units @ $0
12/06/2011 4 Richardson William W (Sr. VP Global Bus. Development) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Unknown transaction of 90 shares @ $24.98, valued at $2.2k
Disposed/sold 1,144 shares @ $33.25, valued at $38k
Disposed/sold 15,000 options to buy @ $27.27, valued at $409.1k
Disposed/sold 6,250 options to buy @ $26.64, valued at $166.5k
Disposed/sold 12,939 options to buy @ $20.45, valued at $264.6k
Disposed/sold 12,939 options to buy @ $25.74, valued at $333k
Disposed/sold 7,246 options to buy @ $19.94, valued at $144.5k
Disposed/sold 7,246 options to buy @ $37.69, valued at $273.1k
Disposed/sold 15,526 options to buy @ $43.26, valued at $671.7k
Disposed/sold 23,289 options to buy @ $32.47, valued at $756.2k
Disposed/sold 51,753 options to buy @ $27.84, valued at $1.4M
12/06/2011 4 MARIO ERNEST (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 214,750 shares @ $33.25, valued at $7.1M
Disposed/sold 193,069 shares @ $33.25, valued at $6.4M
Disposed/sold 58,244 shares @ $33.25, valued at $1.9M
Disposed/sold 6,000 shares @ $33.25, valued at $199.5k
Disposed/sold 9,090 options to buy @ $24.26, valued at $220.5k
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
Disposed/sold 10,496 options to buy @ $24.52, valued at $257.4k
Disposed/sold 14,053 options to buy @ $19.19, valued at $269.7k
Disposed/sold 5,650 options to buy @ $22.98, valued at $129.8k
Disposed/sold 4,113 options to buy @ $34.18, valued at $140.6k
Disposed/sold 6,341 options to buy @ $32.67, valued at $207.2k
12/06/2011 4 MAGNUSON TERRY (10% Owner) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 17,633 shares @ $33.25, valued at $586.3k
Disposed/sold 9,090 options to buy @ $24.26, valued at $220.5k
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
Disposed/sold 10,496 options to buy @ $24.52, valued at $257.4k
Disposed/sold 14,053 options to buy @ $19.19, valued at $269.7k
Disposed/sold 6,485 options to buy @ $41.32, valued at $268k
Disposed/sold 6,341 options to buy @ $32.67, valued at $207.2k
Disposed/sold 12,421 options to buy @ $12.37, valued at $153.6k
Disposed/sold 16,561 options to buy @ $13.12, valued at $217.3k
Disposed/sold 16,561 options to buy @ $15.28, valued at $253.1k
Disposed/sold 5,650 options to buy @ $22.98, valued at $129.8k
12/06/2011 4 Wilkinson Michael O. (Chief Information Officer) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Unknown transaction of 280 shares @ $24.98, valued at $7k
Disposed/sold 2,362 shares @ $33.25, valued at $78.5k
Disposed/sold 12,485 options to buy @ $25.74, valued at $321.4k
Disposed/sold 21,052 options to buy @ $20.45, valued at $430.5k
Disposed/sold 15,000 options to buy @ $26.64, valued at $399.6k
Disposed/sold 6,211 options to buy @ $19.94, valued at $123.8k
Disposed/sold 18,632 options to buy @ $37.69, valued at $702.2k
Disposed/sold 7,763 options to buy @ $43.26, valued at $335.8k
Disposed/sold 62,104 options to buy @ $33.8, valued at $2.1M
Disposed/sold 10,000 restricted stock units @ $0
12/06/2011 4 INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 1,139 shares @ $33.25, valued at $37.9k
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
12/06/2011 4 HARTMAN JUDD (General Counsel) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 6,211 options to buy @ $19.94, valued at $123.8k
Disposed/sold 34,503 options to buy @ $20.45, valued at $705.6k
Disposed/sold 45,000 options to buy @ $27.27, valued at $1.2M
Disposed/sold 25,000 options to buy @ $26.64, valued at $666k
Disposed/sold 36,227 options to buy @ $25.74, valued at $932.5k
Disposed/sold 18,632 options to buy @ $37.69, valued at $702.2k
Disposed/sold 46,630 options to buy @ $43.26, valued at $2M
Disposed/sold 41,403 options to buy @ $33.44, valued at $1.4M
Disposed/sold 15,526 options to buy @ $32.47, valued at $504.1k
Disposed/sold 15,000 restricted stock units @ $0
12/06/2011 4 FRANK FRED (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 72,565 shares @ $33.25, valued at $2.4M
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
Disposed/sold 9,090 options to buy @ $24.26, valued at $220.5k
Disposed/sold 10,496 options to buy @ $24.52, valued at $257.4k
Disposed/sold 14,053 options to buy @ $19.19, valued at $269.7k
Disposed/sold 6,485 options to buy @ $41.32, valued at $268k
Disposed/sold 6,341 options to buy @ $32.67, valued at $207.2k
Disposed/sold 4,113 options to buy @ $34.18, valued at $140.6k
Disposed/sold 12,421 options to buy @ $12.37, valued at $153.6k
Disposed/sold 16,561 options to buy @ $13.12, valued at $217.3k
Disposed/sold 16,561 options to buy @ $14.55, valued at $241k
12/06/2011 4 ESHELMAN FREDRIC N (Executive Chairman) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed of 15,000 shares @ $0
Acquired 15,000 shares @ $0
Disposed/sold 6,984,741 shares @ $33.25, valued at $232.2M
Disposed/sold 394,500 shares @ $33.25, valued at $13.1M
Disposed/sold 11,258 shares @ $33.25, valued at $374.3k
Disposed/sold 1,685 shares @ $33.25, valued at $56k
Disposed/sold 90,000 options to buy @ $27.27, valued at $2.5M
Disposed/sold 103,506 options to buy @ $20.45, valued at $2.1M
Disposed/sold 103,506 options to buy @ $25.74, valued at $2.7M
Disposed/sold 51,753 options to buy @ $19.94, valued at $1M
Disposed/sold 103,506 options to buy @ $43.26, valued at $4.5M
12/06/2011 4 Dingivan Christine A (EVP/Chief Medical Officer) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 45,000 options to buy @ $27.27, valued at $1.2M
Disposed/sold 20,000 options to buy @ $26.64, valued at $532.8k
Disposed/sold 41,403 options to buy @ $20.45, valued at $846.7k
Disposed/sold 31,052 options to buy @ $25.74, valued at $799.3k
Disposed/sold 7,763 options to buy @ $19.94, valued at $154.8k
Disposed/sold 7,763 options to buy @ $37.69, valued at $292.6k
Disposed/sold 93,156 options to buy @ $36.65, valued at $3.4M
Disposed/sold 15,000 restricted stock units @ $0
12/06/2011 4 Darazsdi Daniel G (CFO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Unknown transaction of 323 shares @ $24.98, valued at $8.1k
Disposed/sold 13,195 shares @ $33.25, valued at $438.7k
Disposed/sold 30,000 options to buy @ $26.64, valued at $799.2k
Disposed/sold 45,000 options to buy @ $27.27, valued at $1.2M
Disposed/sold 62,104 options to buy @ $20.45, valued at $1.3M
Disposed/sold 62,104 options to buy @ $25.74, valued at $1.6M
Disposed/sold 23,289 options to buy @ $19.94, valued at $464.4k
Disposed/sold 23,289 options to buy @ $37.69, valued at $877.8k
Disposed/sold 46,578 options to buy @ $43.26, valued at $2M
Disposed/sold 93,156 options to buy @ $34.15, valued at $3.2M
Disposed/sold 15,000 restricted stock units @ $0
12/06/2011 4 COLVIN PAUL (EVP--Clinical Development) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Unknown transaction of 20 shares @ $24.98, valued at $499.6
Disposed/sold 45 shares @ $33.25, valued at $1.5k
Disposed/sold 3,753 options to buy @ $19.94, valued at $74.8k
Disposed/sold 11,041 options to buy @ $20.45, valued at $225.8k
Disposed/sold 30,000 options to buy @ $27.27, valued at $818.1k
Disposed/sold 16,000 options to buy @ $26.64, valued at $426.2k
Disposed/sold 15,992 options to buy @ $25.74, valued at $411.6k
Disposed/sold 11,386 options to buy @ $37.69, valued at $429.1k
Disposed/sold 15,526 options to buy @ $43.26, valued at $671.7k
Disposed/sold 31,052 options to buy @ $37.51, valued at $1.2M
Disposed/sold 10,000 restricted stock units @ $0
12/06/2011 4 BRYSON VAUGHN D (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 1,139 shares @ $33.25, valued at $37.9k
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
12/06/2011 4 BONDURANT STUART (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 21,479 shares @ $33.25, valued at $714.2k
Disposed/sold 9,095 options to buy @ $28.52, valued at $259.4k
Disposed/sold 10,496 options to buy @ $24.52, valued at $257.4k
Disposed/sold 14,053 options to buy @ $19.19, valued at $269.7k
Disposed/sold 6,485 options to buy @ $41.32, valued at $268k
Disposed/sold 6,341 options to buy @ $32.67, valued at $207.2k
Disposed/sold 4,113 options to buy @ $34.18, valued at $140.6k
Disposed/sold 5,650 options to buy @ $22.98, valued at $129.8k
12/06/2011 4 Babiss Lee (Exec. VP--Global Lab Services) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Txns: Disposed/sold 30,000 options to buy @ $27.27, valued at $818.1k
Disposed/sold 15,000 options to buy @ $26.64, valued at $399.6k
Disposed/sold 46,578 options to buy @ $20.45, valued at $952.5k
Disposed/sold 10,000 restricted stock units @ $0
12/05/2011 8-K Quarterly results
12/05/2011 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
11/15/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/14/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/10/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy